What are the admission and discharge criteria for patients with dengue fever?

Admission and Discharge Criteria for Dengue Fever

Admission Criteria

Admit any dengue patient who presents with warning signs, clinical or laboratory evidence of plasma leakage, bleeding manifestations, or hemodynamic instability; patients without any warning signs can be safely managed with daily outpatient monitoring. 1

Clinical Warning Signs Requiring Admission

• Abdominal pain or tenderness – present in 13% of hospitalized cases and indicates potential plasma leakage 2
• Persistent vomiting – reported in 33% of admitted patients and significantly associated with self-referral to hospital 2
• Clinical fluid accumulation (pleural effusion, ascites) – found in 15.5% of hospitalized DHF patients versus only 2.9% of outpatients 3
• Mucosal bleeding – occurred in 18% of hospitalized cases, though bleeding does not correlate directly with platelet count 2
• Lethargy or restlessness – a key warning sign for disease progression 1
• Liver enlargement >2 cm 1
• Hypotension or signs of shock – requires immediate admission 2

Laboratory Criteria for Admission

• Platelet count <50,000/μL – this threshold identifies patients at higher risk, as 50% of hospitalized patients had platelets between 50,000-80,000/μL and did well 2
• Rising hematocrit concurrent with rapid platelet decline – indicates plasma leakage 3
• Hypoproteinemia – present in 92.7% of DHF outpatients who recovered uneventfully, but when combined with clinical fluid accumulation warrants admission 3
• Significant leukopenia with warning signs 4

Risk Stratification by Patient Characteristics

• Adults are more likely to present late and should have a lower threshold for admission when warning signs are present 5
• Pregnant women require admission due to increased risk of maternal death, hemorrhage, pre-eclampsia, eclampsia, and vertical transmission 4
• Patients with comorbidities (diabetes, hypertension, cardiovascular disease) warrant admission even with mild warning signs 3

Outpatient Management Criteria

Patients without any warning signs have a 91% negative predictive value for DHF I-IV and 100% for severe dengue, making ambulatory care safe and feasible. 1

Safe for Outpatient Management When ALL of the Following Are Present:

• No warning signs on clinical examination 1
• Platelet count ≥50,000/μL – levels between 50,000-80,000/μL are safe if no other warning signs present 2
• Stable hematocrit without evidence of hemoconcentration 3
• Tolerating oral fluids and maintaining adequate hydration 2
• Reliable patient who can return for daily monitoring 2
• Access to medical care within 24 hours if condition worsens 1

Outpatient Monitoring Protocol

• Daily clinical assessment for development of warning signs 2
• Daily complete blood count to track platelet nadir and hematocrit changes 2
• Patient education on warning signs, as 51.3% of patients who progressed to severe illness had warning signs the day before deterioration 1
• Medical leave with symptomatic treatment (antipyretics, oral rehydration) 2

Discharge Criteria

Discharge is appropriate when the patient demonstrates clinical improvement, stable vital signs, rising platelet count, and can maintain oral intake without intravenous fluid support.

Clinical Criteria for Discharge

• Afebrile for 24-48 hours without antipyretics 3
• Improvement in clinical well-being with resolution of warning signs 1
• Stable hemodynamics without orthostatic changes 3
• Adequate oral intake and urine output maintained 2
• No respiratory distress or signs of fluid overload 3

Laboratory Criteria for Discharge

• Platelet count trending upward – note that only 9% of patients had nadir below 20,000/μL and only 2% below 10,000/μL, so absolute threshold is less important than trend 2
• Stable or decreasing hematocrit indicating resolution of plasma leakage 3
• No requirement for platelet transfusion in preceding 24 hours 3

Post-Discharge Monitoring

• Follow-up within 48-72 hours to confirm continued platelet recovery 2
• Patient counseling on gradual return to activities and signs of relapse 1

Critical Implementation Considerations

Avoiding Over-Hospitalization

• Implementation of evidence-based admission criteria reduced hospitalizations by 33% without increasing adverse outcomes 3
• Cost savings of US$1.4 million were achieved by appropriate outpatient management 3
• 68 DHF cases were managed safely as outpatients after implementing stricter criteria 3
• The window from warning sign onset to severe illness is typically <24 hours, making daily outpatient monitoring sufficient 1

Avoiding Under-Triage

• All ICU admissions and deaths occurred among inpatients, indicating that current criteria successfully identify high-risk patients 3
• Late admission is associated with higher case fatality rates in children, severe disease, and public tertiary hospitals 5
• Medical referral to hospital is significantly associated with thrombocytopenia, suggesting physicians appropriately identify laboratory risk factors 2

Fluid Management Pitfall

• High-volume IV fluids (>2000 mL/day) increase the risk of progression to severe dengue in patients <55 years old and those with warning signs (HR: 1.77) 6
• Judicious fluid administration is warranted – avoid aggressive hydration in non-shock patients 6
• Low-volume IV fluids (<1000 mL/day) may be protective in patients without warning signs (HR: 0.757) 6